By Cynthia Kim and Hyunjoo Jin SEOUL, July 7 (Reuters) - U.S. chip design giant Synopsys plans to stop offering a suite of ...
InvestorsHub on MSN
Synopsys to phase out chip manufacturing software as AI design becomes strategic focus (SNPS)
Synopsys shifts resources away from manufacturing software Synopsys (NASDAQ:SNPS) is preparing to discontinue a suite of ...
Even after 20 years or so, process control continues to be a confusing or misunderstood technology. A short description of process control is an accurate one—It’s a means of controlling manufacturing ...
Synopsys is preparing to discontinue a suite of manufacturing process control software used by semiconductor manufacturers, ...
Software enhancements for medical device, pharmaceutical and biotechnology teams support regulatory readiness, traceability ...
With PAT, pharmaceutical manufacturers achieve real-time process control, enhancing drug quality and accelerating the ...
A medical device manufacturer ditched a clunky ERP module for quality inspection, opting instead for specialized statistical process control software. Upgrading to new software costs time and money ...
Validate it? I just want to use it! Sound familiar? Most companies in the medical device industry understand and accept the need to validate software that is critical to the functioning of a medical ...
Additive manufacturing, also known as 3D printing, has had a major impact on the contemporary design and production process. First developed in 1988 with the aim of allowing for rapid prototyping, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results